Log In
BCIQ
Print this Print this
 

PBD-C06

  Manage Alerts
Collapse Summary General Information
Company Probiodrug AG
DescriptionHumanized and de-immunized mAb targeting a pyroglutamated form of beta amyloid
Molecular Target Beta amyloid
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today